Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00, Prague 7, Czech Republic
Megace 160 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. Off-white, oval, biconvex tablets with a break line, engraved ‘160’ on one face. The break line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains Megestrol Acetate 160 mg.
Excipient with known effect: Each tablet contains 224.5 mg Lactose Monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Megestrol |
Megestrol possesses pharmacological properties similar to those of natural progesterone. Megestrol acetate is a potent progestogen that exerts significant anti-oestrogenic effects. It has no androgenic or oestrogenic properties. |
| List of Excipients |
|---|
|
Colloidal anhydrous silica |
Amber glass bottles of 30, 60 or 100.
Blister packs of 30 tablets.
PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00, Prague 7, Czech Republic
PL 33616/0001
20 November 1985 / 25 April 2002
| Drug | Countries | |
|---|---|---|
| MEGACE | Cyprus, France, Croatia, Ireland, Italy, Lithuania, Poland, Singapore, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
